Patients with kidney disease, especially those with kidney failure, are particularly susceptible to the adverse effects of disasters because their survival depends on functional infrastructure, advanced technology, the availability of specific drugs and well-trained medical personnel. The risk of poor outco...
The test is usually done to diagnosekidney diseaseand to evaluate the extent of damage to the kidney. A biopsy is also frequently ordered to detect the reason for acute renal failure when normal office procedures and tests fail to establish the cause. In addition, information regarding the progr...
Davison SN, Levin A, Moss AH, et al; Kidney Disease: Improving Global Outcomes. Executive summary of the KDIGO Controversies Conference on Supportive Care in Chronic Kidney Disease: developing a roadmap to improving quality care. Kidney Int. 2015;88(3):447-459. doi:10.1038/...
The incidence rate of stage IV chronic kidney disease increased with age. For those 75 years and older, the risk of death was much higher than that of kidney failure. The high burden of chronic kidney disease is also expected to boost the market, as this will increase demand for renal dia...
According to WHO, in the past 9 years, the incidence of kidney disease has increased to become one of the top 10 prominent causes of death globally. According to National Kidney Foundation, Inc., an estimated 37 million people in the U.S., i.e., more than one in seven adults, are ...
Since the rollout of combination antiretroviral therapy, the extent of HIV infection and kidney disease continues to be modified and possibly retarded. Am J Kidney Dis. 60(4): 668-678. (C) 2012 by the National Kidney Foundation, Inc. 展开 ...
The Kidney Disease Market raise at a CAGR of 5.50% & reach USD 148.43 billion by 2029. It is fragmented into type, drug type, treatment, dosage form, end user, distribution channel.
South Africa; King's College Hospital NHS Foundation Trust, London, UK; Basic Research Laboratory, Center for Cancer Research, National Cancer Institute, National Institutes of Health and Leidos Biomedical Research, Frederick National Laboratory, Frederick, Maryland, USA; KDIGO, Brussels, Belgium; Unive...
Thus, the significant burden of chronic kidney disease and kidney cancer is projected to augment the demand for artificial kidneys to restore normal kidney functions, which, in turn, is projected to boost market growth during the forecast period. In addition, the increased funding activities for ...
For instance, Africa, the Middle East, and South Asia had low prevalence of treated end-stage renal disease in comparison with North America and Western Europe (where the prevalence was generally above 1000 per 1 million population) (Figure 1). Overall, only 9 (7.7%) and 8 (6.8%) ...